Composition of low-osmotic-pressure high-protein oligopeptide type enteral nutrition preparation
By optimizing the formula, controlling the osmotic pressure and protein molecular weight distribution, the diarrhea problem caused by high osmotic pressure of short peptide enteral nutrition preparations is solved, improving the tolerance and safety of the preparations, ensuring high protein content while reducing diarrhea risk.
Patent Information
- Application Number
- CN202411291055.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-12-06
AI Technical Summary
Short peptide enteral nutritional preparations have limited their safety and tolerance in ICU patients due to diarrhea problems caused by high osmotic pressure.
By optimizing the formula, including using carbohydrates such as maltodextrin and cassava dextrin, hydrolyzing high-molecular weight proteins such as whey protein, combining specific minerals and vitamins, the osmotic pressure is controlled within the range of 280-460mOsmol/kg to form a low osmotic pressure High-protein short peptide enteral nutritional preparation.
Effectively regulate the osmotic pressure of enteral nutritional preparations, improve their tolerance in special medical uses, ensure that the protein content reaches 15% or more, and reduce the risk of diarrhea.
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of nutritional foods and health products, and more specifically to a composition of a low-osmotic pressure, high-protein, short-peptide enteral nutrition preparation. Background Art
[0002] Enteral nutrition preparations can be classified into amino acid type, short peptide type, and whole protein type according to the nitrogen source. The first two types of preparations mainly use amino acids or protein hydrolysates as nitrogen sources, so they can be directly or almost directly absorbed by the small intestine. For patients with incomplete or low gastrointestinal function, such as digestion and absorption disorders caused by disease or surgery, slow gastric emptying, reduced absorption area, poor digestion and absorption, insufficient gastric motility, and reduced secretion of gastrointestinal hormones and digestive juices, short peptide / amino acid type enteral nutrition preparations are preferred.
[0003] Short peptides refer to peptide chains composed of 2 to 10 amino acids, which are between amino acids and proteins and constitute a unique bioactive substance. The main form of protein absorption in the normal human body is short peptides (about 67%), followed by free amino acids (about 33%); compared with amino acids, short peptides have faster speed and higher efficiency, and amino acids enter the small intestinal mucosal cells through transmembrane transport; short peptides have two absorption channels, one is that small peptides (dipeptides and tripeptides) are directly absorbed by intestinal mucosal cells, and the other is that under the action of intestinal mucosal cell oligopeptidases, short peptides are finally hydrolyzed into amino acids; the transport mechanisms of short peptides and amino acids are independent and completely different from each other. Even in the case of loss or congenital defects of the free amino acid transport system, or decreased small intestinal function, short peptides can help quickly supplement nutrition. However, short peptide enteral nutrition preparations use hydrolyzed proteins, have more free small molecules, and have higher osmotic pressure than whole protein preparations, which greatly limits the amount of hydrolyzed protein added to this type of formula.
[0004] Nutrients in the intestine must be isotonic (osmotic pressure 280-310mOsmol / kg). When hypertonic fluid (osmotic pressure > 350mOsmol / kg) enters the intestinal cavity, water moves from the hypotonic fluid (plasma) to the hypertonic fluid (intestinal cavity), diluting the hypertonic fluid to an isotonic state. When ICU patients use high-osmotic pressure short-peptide enteral nutrition preparations, osmotic diarrhea is very likely to occur, resulting in adverse outcomes. Therefore, regulating the instant osmotic pressure of short-peptide enteral nutrition preparations plays an extremely important role in improving the safety and tolerability of the formula. Summary of the invention
[0005] In view of this, the technical solution of the present invention provides a composition of a low-osmotic pressure, high-protein short-peptide enteral nutrition preparation to solve the intolerance problems such as diarrhea caused by high osmotic pressure during the use of short-peptide enteral nutrition preparations.
[0006] To achieve the above object, the present invention adopts the following technical solution:
[0007] A composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation, comprising, by weight:
[0008] 35-60 parts of carbohydrates, 5-30 parts of fat powder, 18-30 parts of protein, 0.1-10 parts of complex minerals, 0.1-2 parts of complex vitamins;
[0009] Wherein, the carbohydrate is one or more of maltodextrin, tapioca dextrin, and highly branched cyclodextrin;
[0010] In the distribution range of the molecular weight of the protein, 1000 Da accounts for no less than 50%.
[0011] Preferably, the maltodextrin is MD10 maltodextrin, MD15 maltodextrin or MD20 maltodextrin.
[0012] Preferably, the fat powder is made from vegetable oil, emulsifier, wall material, and acidity regulator through homogenization and spray drying, specifically:
[0013] Add vegetable oil, emulsifier, wall material and acidity regulator into the dissolving tank according to the fat-soluble raw materials and water-soluble raw materials respectively, keep warm and stir at 50-60℃ to completely dissolve them, shear at 5000-15000r / min for 10-20min to form a uniform mixed liquid; put the mixed liquid into a high-pressure homogenizer, and homogenize it continuously at 20-60MPa for ≥2 times; then spray dry it in a spray drying tower, with an inlet air temperature of 120℃-190℃ and an outlet air temperature of 60-85℃.
[0014] Preferably, the wall material is one or more of maltodextrin, tapioca dextrin, high-branched cyclodextrin, starch, isomaltulose, trehalose, crystalline fructose, maltitol, isomalt, and xylitol; the emulsifier is one or more of sodium caseinate, casein, citric acid fatty acid glyceride, mono- and diglycerol fatty acid esters, caprylic and capric glycerides; the vegetable oil is one or more of medium-chain triglycerides, docosahexaenoic acid oil, eicosapentaenoic acid oil, arachidonic acid oil, 1,3-dioleyl-2-palmityl triglyceride, rapeseed oil, low-erucic acid rapeseed oil, corn oil, soybean oil, sunflower oil, high oleic sunflower oil, peanut oil, high oleic peanut oil, palm oil, palm olein, palm kernel oil, olive oil, coconut oil, linseed oil, safflower seed oil, walnut oil, and peony seed oil; the acidity regulator is one or more of potassium citrate, sodium citrate, sodium dihydrogen phosphate, and disodium hydrogen phosphate;
[0015] Preferably, the protein includes but is not limited to one or more of hydrolyzed whey protein and soy peptide.
[0016] Preferably, the composite mineral comprises, by weight: 0.1-2 parts of ferric pyrophosphate, 0.1-2 parts of zinc gluconate, 1-10 parts of calcium carbonate, 3-18 parts of calcium hydrogen phosphate, and 3-10 parts of magnesium carbonate.
[0017] Preferably, the complex vitamin comprises, by weight: 0.4-0.7 parts of retinyl acetate, 0.1-0.4 parts of cholecalciferol, 1-4 parts of dl-α tocopherol acetate, 0.04-0.09 parts of thiamine hydrochloride, 0.04-0.09 parts of riboflavin, 0.1-0.5 parts of pyridoxine hydrochloride, 0.1-0.5 parts of cyanocobalamin, 0.1-0.9 parts of niacinamide, 0.01-0.09 parts of folic acid, 0.1-0.9 parts of D-calcium pantothenate, and 8-16 parts of sodium L-ascorbate.
[0018] It can be seen from the above technical solution that, compared with the prior art, the present invention discloses a composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation, which has the following beneficial effects:
[0019] The composition can adjust (increase or decrease) the osmotic pressure of enteral nutrition preparations, especially complete nutritional foods for special medical purposes, in a ready-to-eat state. Under isocaloric preparation (1 kcal / ml) conditions, the protein content can reach 15% or more as determined by the method for determining protein in food in accordance with GB 5009.5, the national food safety standard.
[0020] This program controls the molecular weight distribution of hydrolyzed protein and selects the dosage form of minerals. It utilizes the specific structure and function of hydrolyzed protein to chelate metal ions to form stable complexes, and adjusts the formula ratio to control the osmotic pressure within 280-460mOsmol / kg, which is beneficial to improving the in vivo tolerance of enteral nutrition preparations. DETAILED DESCRIPTION
[0021] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0022] Example 1
[0023] Preparation of fat powder:
[0024] In parts by weight, 10 parts of linseed oil, 0.5 parts of docosahexaenoic acid oil, 2 parts of eicosapentaenoic acid oil, 50 parts of medium-chain triglycerides, 4 parts of sodium ascorbate, 1 part of sodium citrate, 0.5 parts of mono- and di-glycerol fatty acid esters, and 32 parts of sodium starch octenylsuccinate are added to a dissolving tank. The linseed oil, docosahexaenoic acid oil, eicosapentaenoic acid oil, medium-chain triglycerides, sodium ascorbate, and mono- and di-glycerol fatty acid esters are kept warm at 50° C. and stirred to completely dissolve, which is the oil phase. Add sodium citrate and sodium starch octenylsuccinate into a dissolving tank, add an equal amount of water, keep warm at 50°C and stir to completely dissolve, which is the water phase; mix the oil phase and the water phase, shear at 10000r / min for 15min to form a uniform mixed liquid; put the mixed liquid into a high-pressure homogenizer, and homogenize it continuously at 25MPa for 2 times; then spray dry it in a spray drying tower, with an inlet air temperature of 180°C and an outlet air temperature of 80°C.
[0025] Weigh 40 parts of maltodextrin (MD10), 5 parts of fat powder, 18 parts of hydrolyzed whey protein powder, 0.1 part of complex minerals (by weight: 1.2 parts of ferric pyrophosphate, 0.5 parts of zinc gluconate, 5 parts of calcium carbonate, 10 parts of calcium hydrogen phosphate, 8 parts of magnesium carbonate), 0.1 part of complex vitamins (by weight: 0.3 parts of retinyl acetate, 0.2 parts of cholecalciferol, 3 parts of dl-α tocopherol acetate, 0.06 parts of thiamine hydrochloride, 0.05 parts of riboflavin, 0.2 parts of pyridoxine hydrochloride, 0.2 parts of cyanocobalamin, 0.8 parts of niacinamide, 0.06 parts of folic acid, 0.6 parts of D-calcium pantothenate, 10 parts of L-sodium ascorbate), put them into a three-dimensional motion mixer, set the mixing speed to 10 r / min, and the mixing time to 30 min. Take the mixed materials, add warm water at about 50°C to prepare an isocaloric solution, and measure the osmotic pressure of the obtained solution, the result is 315mOsmol / kg.
[0026] Example 2
[0027] Maltodextrin (MD10) was replaced with maltodextrin (MD20), and the other ingredients were kept the same as those in Example 1, and the mixture was put into a three-dimensional motion mixer, and the mixing speed was set to 10 r / min and the mixing time was set to 30 min. The mixed materials were taken, and warm water at about 50° C. was added to prepare an isocaloric solution, and the osmotic pressure of the obtained solution was measured, and the result was 458 mOsmol / kg.
[0028] Example 3
[0029] Preparation of fat powder:
[0030] In parts by weight, 15 parts of rapeseed oil, 30 parts of soybean oil, 30 parts of medium chain triglycerides, 1 part of potassium citrate, 0.5 parts of mono- and di-glycerol fatty acid esters, and 23.5 parts of maltodextrin (MD10);
[0031] Add rapeseed oil, soybean oil, medium-chain triglycerides, mono- and di-glycerol fatty acid esters into a dissolving tank, keep warm at 50°C and stir until they are completely dissolved, which is the oil phase. Add potassium citrate and maltodextrin (MD10) into a dissolving tank, add an equal amount of water, keep warm at 50°C and stir until they are completely dissolved, which is the water phase. Mix the oil phase and the water phase, shear at 8000r / min for 20min to form a uniform mixed liquid; put the mixed liquid into a high-pressure homogenizer, and homogenize it continuously at 30MPa for 2 times; then spray dry it in a spray drying tower, with an inlet air temperature of 180°C and an outlet air temperature of 75°C.
[0032] Weigh 40 parts of cassava dextrin, 20 parts of fat powder, 18 parts of soybean peptide powder, 0.1 parts of composite minerals (by weight: 1 part of ferric pyrophosphate, 0.8 parts of zinc gluconate, 4 parts of calcium carbonate, 8 parts of calcium hydrogen phosphate, 7 parts of magnesium carbonate), 0.1 parts of composite vitamins (by weight: 0.4 parts of retinyl acetate, 0.3 parts of cholecalciferol, 2 parts of dl-α tocopherol acetate, 0.06 parts of thiamine hydrochloride, 0.05 parts of riboflavin, 0.1 parts of pyridoxine hydrochloride, 0.3 parts of cyanocobalamin, 0.6 parts of nicotinamide, 0.06 parts of folic acid, 0.6 parts of D-calcium pantothenate, 6 parts of sodium L-ascorbate), put into a three-dimensional motion mixer, set the mixing speed to 10r / min, and the mixing time to 30min. Take the mixed materials, add warm water at about 50°C, prepare an isocaloric solution, and measure the osmotic pressure of the resulting solution, the result is 342mOsmol / kg.
[0033] Example 4
[0034] Preparation of fat powder:
[0035] In parts by weight, 10 parts of high oleic sunflower oil, 15 parts of rapeseed oil, 1 part of potassium citrate, 25 parts of medium chain triglycerides, 0.5 parts of mono- and di-glycerol fatty acid esters, and 48.5 parts of tapioca dextrin; high oleic sunflower oil, rapeseed oil, medium chain triglycerides, and mono- and di-glycerol fatty acid esters are stirred at 60°C to completely dissolve, which is the oil phase. Potassium citrate and tapioca dextrin are added to a dissolving tank, and water of equal mass is added, and stirred at 50°C to completely dissolve, which is the water phase. The oil phase and the water phase are mixed, and sheared at 8000r / min for 20min to form a uniform mixed solution; the mixed solution is injected into a high-pressure homogenizer, and homogenized at 30MPa for two times; and then spray-dried in a spray drying tower, with an inlet air temperature of 175°C and an outlet air temperature of 75°C.
[0036] Weigh 35 parts of maltodextrin (MD10), 15 parts of fat powder, 30 parts of hydrolyzed whey protein powder, 5 parts of complex minerals (by weight: (1 part of ferric pyrophosphate, 0.8 parts of zinc gluconate, 4 parts of calcium carbonate, 8 parts of calcium hydrogen phosphate, 7 parts of magnesium carbonate), 0.1 parts of complex vitamins (by weight: 0.4 parts of retinyl acetate, 0.3 parts of cholecalciferol, 2 parts of dl-α tocopherol acetate, 0.06 parts of thiamine hydrochloride, 0.0 5 parts, 0.1 parts of pyridoxine hydrochloride, 0.3 parts of cyanocobalamin, 0.6 parts of nicotinamide, 0.06 parts of folic acid, 0.6 parts of D-calcium pantothenate, 6 parts of L-sodium ascorbate), put into a three-dimensional motion mixer, set the mixing speed to 10r / min, and the mixing time to 30min. Take the mixed materials, add warm water at about 50℃, prepare an isocaloric solution, and measure the osmotic pressure of the obtained solution, the result is 303mOsmol / kg.
[0037] Example 5
[0038] Preparation of fat powder:
[0039] In parts by weight, 15 parts of sunflower oil, 15 parts of soybean oil, 20 parts of medium-chain triglycerides, 0.2 parts of citric acid fatty acid glyceride, 2 parts of sodium dihydrogen phosphate, 0.4 parts of mono- and di-glycerol fatty acid esters, and 47.4 parts of maltodextrin (MD20); sunflower oil, soybean oil, medium-chain triglycerides, citric acid fatty acid glyceride, and mono- and di-glycerol fatty acid esters are stirred at 60°C to completely dissolve, which is the oil phase. Sodium dihydrogen phosphate and maltodextrin (MD20) are added to a dissolving tank, and water of equal mass is added, and stirred at 50°C to completely dissolve, which is the water phase. The oil phase and the water phase are mixed, and sheared at 8000r / min for 20min to form a uniform mixed solution; the mixed solution is injected into a high-pressure homogenizer, and homogenized at 30MPa for two times; and then spray-dried in a spray drying tower, with an inlet air temperature of 180°C and an outlet air temperature of 80°C.
[0040] Weigh 35 parts of highly branched cyclodextrin, 15 parts of fat powder, 30 parts of hydrolyzed whey protein powder, 5 parts of composite minerals (by weight: 1 part of ferric pyrophosphate, 0.8 part of zinc gluconate, 4 parts of calcium carbonate, 8 parts of calcium hydrogen phosphate, 7 parts of magnesium carbonate), 0.1 part of composite vitamins (by weight: 0.6 part of retinyl acetate, 0.3 part of cholecalciferol, 5 parts of dl-α tocopherol acetate, 0.06 part of thiamine hydrochloride, 0.05 part of riboflavin, 0.2 part of pyridoxine hydrochloride, 0.3 part of cyanocobalamin, 0.6 part of niacinamide, 0.06 part of folic acid, 0.6 part of D-calcium pantothenate, 4 parts of L-sodium ascorbate), put them into a three-dimensional motion mixer, set the mixing speed to 10 r / min, and the mixing time to 30 min. Take the mixed materials, add warm water at about 50°C to prepare an isocaloric solution, and measure the osmotic pressure of the obtained solution, the result is 285mOsmol / kg.
[0041] In this specification, each embodiment is described in a progressive manner, and each embodiment focuses on the differences from other embodiments, and the same and similar parts between the embodiments can be referred to each other. The above description of the disclosed embodiments enables professionals and technicians in this field to implement or use the present invention. Various modifications to these embodiments will be obvious to professionals and technicians in this field, and the general principles defined herein can be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to these embodiments shown in this article, but will comply with the widest range consistent with the principles and novel features disclosed herein.
Claims
1. A composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation, characterized in that: In parts by weight, it includes: 35-60 parts of carbohydrates, 5-30 parts of fat powder, 18-30 parts of protein, 0.1-10 parts of complex minerals, 0.1-2 parts of complex vitamins; Wherein, the carbohydrate is one or more of maltodextrin, tapioca dextrin, and highly branched cyclodextrin; In the distribution range of the molecular weight of the protein, 1000 Da accounts for no less than 50%.
2. The composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation according to claim 1, characterized in that: The maltodextrin is MD10 maltodextrin, MD15 maltodextrin or MD20 maltodextrin.
3. The composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation according to claim 1, characterized in that: The fat powder is made from vegetable oil, emulsifier, wall material, and acidity regulator through homogenization and spray drying, specifically: Add vegetable oil, emulsifier, wall material and acidity regulator into the dissolving tank according to the fat-soluble raw materials and water-soluble raw materials respectively, keep warm and stir at 50-60℃ to completely dissolve them, shear at 5000-15000r / min for 10-20min to form a uniform mixed liquid; put the mixed liquid into a high-pressure homogenizer, and homogenize it continuously at 20-60MPa for ≥2 times; then spray dry it in a spray drying tower, with an inlet air temperature of 120℃-190℃ and an outlet air temperature of 60-85℃.
4. The diabetic enteral nutrition preparation composition with adjustable osmotic pressure according to claim 3, characterized in that: The wall material is one or more of maltodextrin, tapioca dextrin, high-branched cyclodextrin, starch, isomaltulose, trehalose, crystalline fructose, maltitol, isomalt, and xylitol; the emulsifier is one or more of sodium caseinate, casein, citric acid fatty acid glyceride, mono- and diglycerol fatty acid esters, caprylic and capric glycerides; the vegetable oil is one or more of medium-chain triglycerides, docosahexaenoic acid oil, eicosapentaenoic acid oil, arachidonic acid oil, 1,3-dioleyl-2-palmityl triglyceride, rapeseed oil, low-erucic acid rapeseed oil, corn oil, soybean oil, sunflower oil, high-oleic sunflower oil, peanut oil, high-oleic peanut oil, palm oil, palm olein, palm kernel oil, olive oil, coconut oil, linseed oil, safflower seed oil, walnut oil, and peony seed oil; the acidity regulator is one or more of potassium citrate, sodium citrate, sodium dihydrogen phosphate, and disodium hydrogen phosphate.
5. The composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation according to claim 1, characterized in that: The protein includes but is not limited to one or more of hydrolyzed whey protein and soy peptide.
6. The composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation according to claim 1, characterized in that: The composite mineral comprises, by weight: 0.1-2 parts of ferric pyrophosphate, 0.1-2 parts of zinc gluconate, 1-10 parts of calcium carbonate, 3-18 parts of calcium hydrogen phosphate, and 3-10 parts of magnesium carbonate.
7. The composition of a low osmotic pressure, high protein, short peptide enteral nutrition preparation according to claim 1, characterized in that: The complex vitamin comprises, by weight: 0.4-0.7 parts of retinyl acetate, 0.1-0.4 parts of cholecalciferol, 1-4 parts of dl-α tocopherol acetate, 0.04-0.09 parts of thiamine hydrochloride, 0.04-0.09 parts of riboflavin, 0.1-0.5 parts of pyridoxine hydrochloride, 0.1-0.5 parts of cyanocobalamin, 0.1-0.9 parts of niacinamide, 0.01-0.09 parts of folic acid, 0.1-0.9 parts of D-calcium pantothenate, and 8-16 parts of sodium L-ascorbate.
